Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 ReNeuron GroupPediapharmPromis NeurosciencesOrgenesisOptiBiotix Health
SymbolLON:RENEN/ATSE:PMNNYSE:ORGSLON:OPTI
Price Information
Current PriceGBX 238N/AC$0.19$4.32GBX 71.40
52 Week RangeN/AN/ABuyBuyN/A
Analyst Ratings
Consensus RecommendationN/AN/ABuyBuyN/A
Consensus Price TargetN/AN/AC$1.00N/AN/A
% Upside from Price TargetN/AN/A426.32% upsideN/AN/A
Trade Information
Market Cap£75.69 millionC$66.36 millionC$53.91 million$65.30 million£61.01 million
BetaN/AN/AN/AN/AN/A
Average Volume28,700100,369263,27631,438197,466
Sales & Book Value
Annual Revenue£900,000.00C$11.16 millionC$475.00N/A£514,289.00
Price / Sales84.100.00104,562.80N/A118.62
CashflowGBX 95.10 per shareN/AC$0.01 per shareN/AGBX 1.59 per share
Price / Cash2.5023.0833.33N/A44.99
Book ValueGBX 100.80 per shareC($0.01) per shareC$0.01 per shareN/AGBX 8.30 per share
Price / Book0.020.0038.00N/A0.09
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (42.30)C($0.07)C($0.05)N/AGBX (2.30)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/A
P/E GrowthN/AC$150.00N/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AC$0.14N/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A186.87%N/AN/AN/A
Current Ratio6.96%1.12%2.43%N/A3.90%
Quick Ratio6.96%0.71%2.20%N/A3.67%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees62N/AN/AN/A8
Shares Outstanding31.80 million221.19 million261.41 million15.62 million85.44 million
Next Earnings DateN/AN/A8/13/2019 (Estimated)7/23/2019 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
 ReNeuron GroupPediapharmPromis NeurosciencesOrgenesisOptiBiotix Health

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel